Loading…
Trace determination of mutagenic alkyl toluenesulfonate impurities via derivatization headspace–GC/MS in an active pharmaceutical ingredient of a candidate drug
[Display omitted] •The mutagenic impurities alkyl toluenesulfonates were derivatized into the corresponding alkyl iodides as analytes by using NaI solution.•It is revealed that Na2S2O3 originally employed in the EP as the antioxidant imposed negative effects on the method robustness.•Vitamin C as an...
Saved in:
Published in: | Journal of pharmaceutical and biomedical analysis 2018-06, Vol.155, p.104-108 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
•The mutagenic impurities alkyl toluenesulfonates were derivatized into the corresponding alkyl iodides as analytes by using NaI solution.•It is revealed that Na2S2O3 originally employed in the EP as the antioxidant imposed negative effects on the method robustness.•Vitamin C as an alternative antioxidant has improved the method robustness and applicability accordingly.•The optimized method has been validated with excellent linearity, precision, accuracy and detection sensitivity.
This study aims to optimize sodium iodide (NaI) derivatization headspace–GC/MS described in European Pharmacopoeia by using vitamin C as an alternative antioxidant for the determination of mutagenic alkyl toluenesulfonate impurities in an active pharmaceutical ingredient (API) of a candidate drug with an artemisinin derivative. Alkyl toluenesulfonates are transformed into their corresponding alkyl iodides (methyl iodide, ethyl iodide, propyl iodide, and isopropyl iodide) by utilizing the derivatization reagent NaI. Results show that the MS response of methyl iodide is a critical indicator of method robustness because of the deteriorating effects of methyl iodide on stability when sodium thiosulfate is used as an antioxidant originally described in the pharmacopoeia. With vitamin C as a newly developed antioxidant, the robustness of this method is improved significantly. The optimized method is further validated and applied successfully for the quality control and safety of the API of an artemisinin derivative. |
---|---|
ISSN: | 0731-7085 1873-264X |
DOI: | 10.1016/j.jpba.2018.03.054 |